Terumo Cardiovascular Group

What Terumo Cardiovascular Group does

Terumo Cardiovascular Group operates as the US-based cardiovascular division of Terumo Corporation, a Japanese multinational medical device company with a history spanning more than 100 years. The legal entity Terumo Cardiovascular Systems Corporation was established in 1979 as the US cardiovascular arm and is headquartered in Ann Arbor, Michigan, with manufacturing operations in Ann Arbor, Elkton (Maryland), and Costa Rica. The company develops, manufactures, and distributes medical devices for cardiac and vascular surgery, with product lines spanning oxygenators (CAPIOX FX Advance and NX19), heart-lung machines (Terumo System 1, Sarns), continuous in-line blood parameter monitoring systems (CDI OneView), endoscopic vessel harvesting systems (VirtuoSaph Plus), perfusion circuits, cannulae, surgical stabilization products, autotransfusion products, and vascular grafts. Its technology base is anchored by the world's first hollow fiber oxygenator (introduced 1979) and proprietary optical fluorescence and optical reflectance sensor technologies used in blood gas and hematocrit monitoring.

The company serves cardiac surgery teams — primarily perfusionists, cardiac and cardiothoracic surgeons, vascular surgeons, and physician assistants / surgical first assistants — across hospitals and cardiac surgery programs worldwide. Its products are positioned to reduce patient morbidity through Goal Directed Perfusion (GDP) strategies aimed at preventing acute kidney injury and through minimally invasive vessel harvesting that materially reduces wound complications versus open techniques. It manufactures the longest-running commercially available line of heart-lung machines globally and claims its CDI systems as the world's most trusted and used continuous in-line blood gas monitors.

Terumo Cardiovascular's business model is a direct enterprise field sales model supported by clinical specialists who deliver in-OR proctoring, simulation-based training, and ongoing clinical education. Revenue is generated through capital equipment sales (heart-lung machines, monitoring systems) plus high-margin recurring consumables (oxygenators, perfusion circuits, EVH disposables, cuvettes), plus multi-year service contracts and clinical training programs. Pricing is non-public and negotiated through direct sales relationships. The company operates a 24/7 online customer support center and a global network of regional sales offices, with commercial presence in at least 13 countries. The company is privately held as a wholly-owned subsidiary of Terumo Corporation (TSE: 4543).

Name

Terumo Cardiovascular Group

Legal name

Terumo Cardiovascular Systems Corporation

Website

https://terumocv.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Terumo Cardiovascular Group is the US-based cardiovascular division of Terumo Corporation, manufacturing and distributing medical devices — oxygenators, heart-lung machines, blood parameter monitoring systems, and endoscopic vessel harvesting systems — for cardiac surgery teams worldwide.

Ownership category

akta.pro rank

Product category

Cardiac Surgery Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

akta.pro secondary industry

Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG)

Keywords

• Cardiac surgery devices
• Cardiopulmonary bypass systems
• Blood parameter monitoring
• Endoscopic vessel harvesting
• Heart-lung machines

Headquarters

HQ city

Ann Arbor

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device and Surgical Equipment Sales: Terumo Cardiovascular generates revenue through the sale of medical devices, surgical equipment, and disposables used in cardiac surgery procedures. Products include oxygenators, heart-lung machines, monitoring systems, endoscopic vessel harvesting systems, cannulae, autotransfusion products, surgical stabilization products, and associated disposables and accessories. Revenue is derived from direct sales to hospitals and cardiac surgery programs.
2. Service, Support, and Training: Terumo Cardiovascular provides service, technical support, and clinical training programs for its equipment. The company offers genuine Terumo Cardiovascular Service for the Terumo Advanced Perfusion System 1, positioning it as a preferred alternative to third-party service providers. Training programs include EVH proctorship, simulation-based training, and clinical education services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Terumo Cardiovascular Group develops, manufactures, and distributes medical devices for cardiac and vascular surgery, with primary product lines in oxygenation systems (CAPIOX hollow fiber oxygenators), heart-lung machines, continuous in-line blood parameter monitoring systems (CDI/OneView), and endoscopic vessel harvesting (EVH) systems (VirtuoSaph Plus). The company sells directly to hospitals and cardiac surgery programs and provides clinical training, proctorship, and equipment service support.

Product overview

Terumo Cardiovascular Group offers a comprehensive portfolio of cardiac surgery technology organized around four core product categories: Perfusion Products (oxygenators, heart-lung machines, perfusion circuits, blood parameter monitoring systems, autotransfusion), Surgical Products (beating heart stabilization, endoscopic vessel harvesting with the VirtuoSaph Plus EVH System, cannulae, vascular grafts), and Monitoring Systems (CDI OneView Monitoring System as the flagship continuous monitoring platform). The CDI OneView system serves as the central real-time monitoring hub, integrating with external heart-lung machines and cerebral oximetry devices, while the VirtuoSaph Plus EVH System handles endoscopic vessel harvesting. Terumo also provides clinical education through its Advanced EVH Training Program and the EVH Experts video series. The company is known for pioneering hollow fiber oxygenation technology and manufacturing the longest-running commercially available heart-lung machine line. Products are available in the United States with regional contact offices worldwide. The company operates manufacturing and quality facilities in Ann Arbor, Michigan, Elkton, Maryland, and Costa Rica.

Differentiator

Problem solved

Functional benefit

Brands

• CDI OneView: Next-generation continuous in-line blood gas monitoring system for perfusionists, measuring up to 22 vital patient parameters including DO2, O2ER, and AUC.
• CAPIOX
• VirtuoSaph Plus
• Terumo System 1
• Terumo Aortic Vascular Grafts
• Sarns
• Xcoating

Products and services

• CDI OneView Monitoring System Continuous in-line blood parameter monitoring system for cardiopulmonary bypass that measures up to 22 vital patient parameters in real time using fluorescence and optical reflectance sensor technology. Designed for perfusionists and cardiac surgery programs to support Goal Directed Perfusion strategies.
• CAPIOX FX Advance Oxygenator Hollow fiber oxygenator in Terumo's CAPIOX family used for cardiopulmonary bypass procedures. Built on the company's pioneering hollow fiber oxygenation technology.
• CAPIOX NX19 Oxygenator Hollow fiber oxygenator in the CAPIOX product line for cardiopulmonary bypass procedures.
• VirtuoSaph Plus EVH System Endoscopic Vessel Harvesting (EVH) system for minimally invasive saphenous vein and radial artery harvesting during cardiac surgery. Uses CO2 insufflation, V-keeper branch capture, V-cutter with bipolar electrosurgical energy, and an integrated lens wiper. Indicated for cardiac surgery programs and PAs performing EVH/ERAH.
• Terumo System 1 (Advanced Perfusion System 1) Advanced perfusion system (heart-lung machine) platform for cardiopulmonary bypass. Terumo manufactures the longest-running line of commercially available heart-lung machines. The company also offers genuine Terumo Cardiovascular Service for the System 1.
• Heart-lung Machines Heart-lung machine product line for cardiopulmonary bypass procedures. Terumo manufactures the longest-running line of commercially available heart-lung machines globally and is a leader in quality systems management.
• Perfusion Circuits Complete extracorporeal perfusion circuits for cardiopulmonary bypass procedures.
• Blood Parameter Monitoring Systems Continuous in-line blood gas monitoring systems including CDI brand monitors — described as the world's most trusted and used continuous in-line blood gas monitors.
• Flex Surgical Stabilization Beating heart surgical stabilization product for off-pump coronary artery bypass procedures.
• Beating Heart & Surgical Stabilization Stabilization devices and systems for beating heart (off-pump) coronary artery bypass surgery.
• Endoscopic Vessel Harvesting (EVH) Products Full portfolio of endoscopic vessel harvesting products including the VirtuoSaph Plus system for saphenous vein and radial artery harvesting in CABG procedures.
• Cannulae Surgical cannulae product family for cardiac surgery procedures.
• Terumo Aortic Vascular Grafts Vascular graft products for aortic surgical procedures.
• Autotransfusion Products Blood salvage and autotransfusion products for reinfusing patient blood during cardiac surgery.
• Advanced EVH Clinical Training Program Comprehensive EVH training program consisting of a dedicated experienced clinical team, proprietary simulation training equipment (Saphenous Vein Model), and state-of-the-art training facilities. Four-step structured program: didactic training, simulation on saphenous vein model, in-OR preparation, and live procedure. For clinicians, PAs, and surgical first assistants learning EVH/ERAH.

Quantifiable outcome

• Reduced AKI risk: A GDP strategy targeting DO2 > 280 mL/min/m2 on CPB was shown to be effective in reducing risk of AKIN stage 1 AKI after cardiac surgery (Ranucci et al., 2018).
• +5 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Fresenius Kabi AGcoreTechnology or IntegrationTerumo distributes and presumably has an integration or distribution relationship for CATSmart® and C.A.T.S.® products, which are registered trademarks of Fresenius Kabi AG. The CATSmart® product is featured on Terumo's product pages and appears to be offered as part of Terumo's perfusion product portfolio. This represents a product distribution/integration partnership where Terumo incorporates or distributes Fresenius Kabi technology.
• Supplier Partner NetworkcoreImplementation/ SI/ Consulting PartnerTerumo Cardiovascular operates a formal Supplier Quality program treating suppliers as partners. Suppliers are expected to meet Terumo's exacting quality standards, comply with FDA QSR requirements, and participate in Terumo's quality system. Terumo requires suppliers to have effective quality systems in place. The company maintains supplier quality contacts in Ann Arbor, Michigan (for CDI and Advanced Perfusion System 1 components), Elkton, Maryland (for oxygenation, surgical stabilization, EVH, and perfusion circuits), and Costa Rica (for custom tubing kits).

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Getinge (Maquet): Getinge's Maquet brand is one of Terumo's primary direct competitors in heart-lung machines, oxygenators, and perfusion circuits used in cardiac surgery, with comparable product breadth across the CPB workflow.
• LivaNova: LivaNova (formerly Sorin Group) directly competes with Terumo in oxygenators, heart-lung machines, and perfusion tubing, and is one of the closest head-to-head competitors in cardiopulmonary bypass consumables.
• Fresenius Kabi: Fresenius Kabi manufactures CATSmart autotransfusion cannulae and related products that Terumo distributes; Fresenius is also a broader competitor in hospital infusion and cardiac surgery products.
• Haemonetics: Haemonetics provides blood management and cardioplegia products (Cardioplegia Plus, LipiGuard) used alongside Terumo's perfusion systems in cardiac surgery, making it a closely aligned competitor and adjacent technology partner.

Broad incumbents

• Stryker: Stryker's surgical instruments and operating-room capital equipment portfolio competes with portions of Terumo's surgical stabilization and cardiac surgery offering, and competes for the same hospital capital budgets.
• Edwards Lifesciences: Edwards Lifesciences is a global leader in heart valves and hemodynamic monitoring; its Fore-Sight Elite cerebral oximetry device integrates with Terumo's CDI OneView, while its structural heart franchise competes in the same operating rooms.
• Medtronic: Medtronic operates broadly across cardiac surgery and cardiac rhythm management; its INVOS cerebral oximetry system integrates with Terumo's CDI OneView platform, while its broader portfolio of structural heart and surgical devices competes for hospital wallet share.
• Abbott (St. Jude Medical / Cardiovascular): Abbott's cardiovascular division competes in cardiac surgery and structural heart products, and its broad hospital portfolio makes it a frequent counterparty in cardiac OR purchasing decisions.

Emerging players

• Xenios (Fresenius Medical Care): Xenios, part of Fresenius Medical Care, is a leading provider of ECMO and cardiopulmonary support systems that use similar oxygenator and pump technology to Terumo's heart-lung machines, representing an adjacent and emerging competitive frontier.

Regional players

• Nipro Corporation: Nipro is a Japanese medical device manufacturer with perfusion and dialyzer product lines that overlap with Terumo's portfolio; it primarily serves Asian markets and competes with Terumo in selected perfusion and hospital categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/terumo_cv
• Facebookfacebook.com/terumocardiovascular

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terumo Cardiovascular Group